ZA694631B - Alkanolamine derivatives - Google Patents

Alkanolamine derivatives

Info

Publication number
ZA694631B
ZA694631B ZA694631*A ZA694631A ZA694631B ZA 694631 B ZA694631 B ZA 694631B ZA 694631 A ZA694631 A ZA 694631A ZA 694631 B ZA694631 B ZA 694631B
Authority
ZA
South Africa
Prior art keywords
alkanolamine derivatives
alkanolamine
derivatives
Prior art date
Application number
ZA694631*A
Other languages
English (en)
Inventor
L Smith
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of ZA694631B publication Critical patent/ZA694631B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA694631*A 1968-07-18 1969-06-30 Alkanolamine derivatives ZA694631B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB34255/68A GB1269775A (en) 1968-07-18 1968-07-18 Alkanolamine derivatives

Publications (1)

Publication Number Publication Date
ZA694631B true ZA694631B (en) 1971-02-24

Family

ID=10363358

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA694631*A ZA694631B (en) 1968-07-18 1969-06-30 Alkanolamine derivatives

Country Status (16)

Country Link
US (1) US3676493A (xx)
JP (1) JPS4842869B1 (xx)
AT (2) AT296256B (xx)
BE (1) BE736231A (xx)
BR (1) BR6910824D0 (xx)
CH (3) CH533596A (xx)
DE (1) DE1936693A1 (xx)
ES (1) ES369624A1 (xx)
FR (1) FR2013209A1 (xx)
GB (1) GB1269775A (xx)
IE (1) IE33184B1 (xx)
IL (1) IL32640A (xx)
NL (1) NL6910914A (xx)
NO (1) NO125445B (xx)
PL (1) PL80101B1 (xx)
ZA (1) ZA694631B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5231858B1 (xx) * 1969-12-17 1977-08-17
GB1312055A (en) * 1970-04-20 1973-04-04 Ici Ltd Alkanolamine derivatives
DE2324176A1 (de) * 1973-05-12 1974-11-28 Bayer Ag Neue katalysatoren und ihre verwendung bei der herstellung von polyurethanen
GB1460593A (en) * 1973-06-22 1977-01-06 Ici Ltd Ethanolamine derivatives
GB1413911A (en) * 1973-08-18 1975-11-12 Pfizer Ltd Preparation of propanolamine derivatives
FI65987C (fi) * 1973-12-12 1984-08-10 Ici Ltd Foerfarande foer framstaellning av nya terapeutiskt anvaendbara alkanolaminderivat
US4165384A (en) * 1974-11-01 1979-08-21 Aktiebolaget Hassle Amide substituted phenoxy propanol amines
US4145443A (en) * 1977-10-31 1979-03-20 Syntex (U.S.A.) Inc. Bicyclo 3.1.0!hexylethylaminocarbonyl-substituted naphthyloxy cardiovascular agents
US4151297A (en) * 1977-10-31 1979-04-24 Syntex (U.S.A.) Inc. Bicyclo [3.1.0] hexyl-substituted ethylamino carbonyl phenoxy cardiovascular agents
US4163053A (en) * 1977-12-27 1979-07-31 Schering Corporation Anti-hypertensive 5-[2-(substituted anilinoalkylamino)-1-hydroxyalkyl]salicylamides
US4428883A (en) 1981-03-06 1984-01-31 The University Of Kentucky Research Foundation Novel method of administering β-blockers and novel dosage forms containing same
JPS58109461A (ja) * 1981-12-24 1983-06-29 Kowa Co 新規ベンズアミド誘導体
US4503075A (en) * 1982-11-12 1985-03-05 A. Menarini S.A.S. Derivatives of 1-alkylamine-3[4(p-alkyloxy-benzamide)phenoxy]-2-propanol, having beta-sympatholytic activity, their salts, and production processes thereof
FR2607812B1 (fr) * 1986-12-05 1989-04-07 Roussel Uclaf Nouveaux derives du benzamide, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
WO1993012069A1 (en) * 1991-12-16 1993-06-24 Yamanouchi Pharmaceutical Co., Ltd. Novel amino alcohol derivative or salt thereof
US6951962B2 (en) * 2002-04-12 2005-10-04 Hercules Incorporated Oil/grease- and water-sizing agent for treatment of cellulosics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE639158A (xx) * 1961-12-05
GB1078852A (en) * 1964-09-30 1967-08-09 Ici Ltd Alkanolamine derivatives

Also Published As

Publication number Publication date
US3676493A (en) 1972-07-11
IE33184L (en) 1970-01-18
GB1269775A (en) 1972-04-06
CH533596A (de) 1973-02-15
CH520103A (de) 1972-03-15
BR6910824D0 (pt) 1973-02-22
AT299914B (de) 1972-07-10
FR2013209A1 (xx) 1970-03-27
IL32640A0 (en) 1969-11-12
ES369624A1 (es) 1971-06-01
DE1936693A1 (de) 1970-01-22
CH539018A (de) 1973-08-31
NO125445B (xx) 1972-09-11
AT296256B (de) 1972-02-10
IE33184B1 (en) 1974-04-17
IL32640A (en) 1975-06-25
JPS4842869B1 (xx) 1973-12-14
BE736231A (xx) 1970-01-19
PL80101B1 (xx) 1975-08-30
NL6910914A (xx) 1970-01-20

Similar Documents

Publication Publication Date Title
IE33906B1 (en) Pyrrolobenzodiazepinone derivatives
MY7500282A (en) Alkanolamine derivatives
MY7500209A (en) Pyridobenzo-diazepine derivatives
CY780A (en) Bromo-ergocryptine
IL30764A0 (en) Alkanolamine derivatives
CY771A (en) N-tritylimidazole
IL33931A0 (en) Alkanolamine derivatives
ZA694631B (en) Alkanolamine derivatives
IL32786A (en) N-phenylsuccinimide derivatives
IL30643A0 (en) Alkanolamine derivatives
IL32462A0 (en) N-substituted lysergamide derivatives
CY728A (en) Omega-cyanoalkylcarbamylbenzimidazoles
IL31277A (en) Phenylurea derivatives
YU15369A (en) Kontaktor z izboljsanim elektromagnetskim krmiljenjem
MY7400293A (en) Ergolene derivatives
ZA697530B (en) Alkanolamine derivatives
ZA71711B (en) Alkanolamine derivatives
YU31646B (en) Ventilna ureditev z razprsilno sobo opremljenega razprsevalnika
MY7400140A (en) Oxazinobenzodiazepine derivatives
KE2686A (en) Alkanolamine derivatives
YU32813B (en) Akumulator z medcelicnimi zvezami
ZA713331B (en) Alkanolamine derivatives
AU435023B2 (en) Alkanolamine derivatives
AU6295669A (en) Alkanolamine derivatives
IE32671L (en) p-AMINOALKYL-BENZENESULFONAMIDE DERIVATIVES